Skip to main content
. Author manuscript; available in PMC: 2022 Jul 1.
Published in final edited form as: J Allergy Clin Immunol Pract. 2021 Apr 21;9(7):2885–2893.e3. doi: 10.1016/j.jaip.2021.04.010

Figure 4: ITCH mRNA and Protein Analysis.

Figure 4:

EBV-transformed B cell mRNA expression analysis demonstrated less than 50% of healthy control ITCH mRNA in the patient (4A).Western blot analysis on patient EBV-transformed B cells and healthy control cells demonstrated that ITCH protein was not expressed in the patient, but was preserved in the controls. Itch expression was normalized to beta actin. (4B)